2023 annual financial data
Aytu BioPharma 2023 Operating margin
Direct answer
Operating margin was -15.89%.
Operating income was -17,065,000 USD and net income was -17,051,000 USD.
Operating cash flow was -5,129,000 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 107,399,000 USD
- Operating income
- -17,065,000 USD
- Net income
- -17,051,000 USD
- Operating cash flow
- -5,129,000 USD